X5DNK3 (X5DNK3_HUMAN) Homo sapiens (Human)
Receptor tyrosine-protein kinase erbB-2 UniProtKBInterProInteractive Modelling
1255 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P04626
It is possible new templates exist for this target since these models were created.
Available Structures
47 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex |
Heteromer P04626; | 2×NAG; 3×NAG; | ||||
Assess | ||||||
Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex |
Heteromer P04626; | 2×NAG; 3×NAG; | ||||
Assess | ||||||
Structure of Zanidatamab bound to HER2 |
Heteromer P04626; | |||||
Assess | ||||||
Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex |
Heteromer P01834; P04626; P0DOX5; Q6GMX6; | 1×NAG; 5×NAG; | ||||
Assess | ||||||
Crystallographic trimer of HER2 extracellular regions in complex with tryptophan-rich antibody frag… |
Heteromer P04626; | 3×NAG; 3×NAG; 3×CL; 48×SO4; | ||||
Assess | ||||||
HuA21-scFv in complex with the extracellular domain(ECD) of HER2 |
Heteromer P04626; | 1×NAG; 1×BMA; | ||||
Assess | ||||||
Crystal structure of extracellular domain of human HER2 complexed with Herceptin Fab |
Heteromer P04626; | 2×NAG; 1×SO4; | ||||
Assess | ||||||
Structure of Trastuzumab Fab mutant in complex with Her2 extracellular domain |
Heteromer P04626; P0DOX5; Q7Z3Y4; | 1×NAG; | ||||
Assess | ||||||
Dual specific bH1 Fab in complex with the extracellular domain of HER2/ErbB-2 |
Heteromer P04626; | 2×NAG; 1×MES; | ||||
Assess | ||||||
Structure of the HER2/HER3/NRG1b Heterodimer Extracellular Domain bound to Trastuzumab Fab |
Heteromer P04626; P21860; Q02297; | 2×NAG; 1×NAG; 5×NAG; | ||||
Assess | ||||||
Structure of the HER2/HER4/BTC Heterodimer Extracellular Domain |
Heteromer P04626; P35070; Q15303; | 2×NAG; 1×NAG; 5×NAG; 2×NAG; 3×NAG; | ||||
Assess | ||||||
Structure of the HER2/HER4/NRG1b Heterodimer Extracellular Domain |
Heteromer P04626; Q02297; Q15303; | 2×NAG; 1×NAG; 5×NAG; 2×NAG; 3×NAG; | ||||
Assess | ||||||
HER2 extracelluar region with affinity matured 3-helix affibody ZHER2:342 |
Heteromer P04626; P38507; | 1×NAG; 2×NAG; | ||||
Assess | ||||||
Crystal structure of extracellular domain of HER2 in complex with Fcab STAB19 |
Heteromer P01857; P04626; | 2×NAG; 2×NAG; 2×GOL; 4×NAG; | ||||
Assess | ||||||
The EREG-bound EGFR/HER2 ectodomain complex |
Heteromer O14944; P00533; P04626; | 1×NAG; 1×NAG; 2×NAG; | ||||
Assess | ||||||
The EGF-bound EGFR/HER2 ectodomain complex |
Heteromer P00533; P01133; P04626; | 1×NAG; 1×NAG; 2×NAG; | ||||
Assess | ||||||
39S Fab bound to HER2 ecd |
Heteromer P04626; | 2×NAG; 1×NAG; | ||||
Assess | ||||||
Crystal structure of extracellular domain of HER2 in complex with Fcab H10-03-6 |
Heteromer P01857; P04626; | |||||
Assess | ||||||
Crystal structure of a HER2-Nb complex |
Heteromer P04626; | 1×NAG; 1×NAG; 2×GOL; | ||||
Assess | ||||||
Molecular Architecture of the ErbB2 Extracellular Domain Homodimer |
Heteromer P04626; | 1×NAG; | ||||
Assess | ||||||
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex |
Heteromer P04626; Q7Z3Y4; | 2×NAG; 1×NAG; | ||||
Assess | ||||||
Structure of HER2 with an Fab |
Heteromer P04626; | |||||
Assess | ||||||
HER2 in complex with Fab MF3958 |
Heteromer P04626; | 1×NAG; 1×NAG; 1×NAG; | ||||
Assess | ||||||
NM-02 in complex with HER2-ECD |
Heteromer P04626; | 1×NAG; 1×NAG; | ||||
Assess | ||||||
Crystal structure of anti-HER2 antibody H2Mab-119 in complex with HER2 domain I |
Heteromer P04626; | 1×NAG; | ||||
Assess | ||||||
Crystal structure of the single-chain Fv (scFv) fragment of an anti-ErbB2 antibody chA21 in complex… |
Heteromer P04626; | |||||
Assess | ||||||
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t… |
Heteromer P04626; | |||||
Assess | ||||||
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t… |
Heteromer P04626; | |||||
Assess | ||||||
Crystal structure of HER2 Domain IV and Rb-H2 |
Heteromer P04626; | 1×NAG; | ||||
Assess | ||||||
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t… |
Heteromer P04626; | |||||
Assess | ||||||
Heterodimeric association of Transmembrane domains of ErbB1 and ErbB2 receptors Enabling Kinase Act… |
Heteromer P00533; P04626; | |||||
Assess | ||||||
Solution structure of the human Grb7-SH2 domain in complex with a 10 amino acid peptide pY1139 |
Heteromer P04626; Q14451; | |||||
Assess | ||||||
Water refined solution structure of the human Grb7-SH2 domain in complex with the 10 amino acid pep… |
Heteromer P04626; Q14451; | |||||
Assess | ||||||
The Structure of ERBIN PDZ domain bound to the Carboxy-terminal tail of the ErbB2 Receptor |
Heteromer P04626; Q96RT1; | |||||
Assess | ||||||
POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTE… |
Heteromer P04439; P04626; P61769; | |||||
Assess | ||||||
PTPN18 in complex with HER2-pY1248 phosphor-peptides |
Heteromer P04626; Q99952; | |||||
Assess | ||||||
Phospholipase C gamma-1 C-terminal SH2 domain bound to a phosphopeptide derived from the receptor t… |
Heteromer P04626; P08487; | |||||
Assess | ||||||
Structural basis of PTPN18 fingerprint on distinct HER2 tyrosine phosphorylation sites |
Heteromer P04626; Q99952; | |||||
Assess | ||||||
The Structure of ERBIN PDZ domain bound to the Carboxy-terminal tail of the ErbB2 Receptor |
Heteromer P04626; Q96RT1; | |||||
Assess | ||||||
Spatial structure of HER2/ErbB2 dimeric transmembrane domain in the presence of cytoplasmic juxtame… | homo-2-mer | |||||
Assess | ||||||
ErbB2 transmembrane segment dimer spatial structure | homo-2-mer | |||||
Assess | ||||||
NMR spatial structure of HER2 TM domain dimer in DPC micelles. | homo-2-mer | |||||
Assess | ||||||
Crystal structure of ErbB2 domains 1-3 | monomer | 1×NAG; 2×NAG; | ||||
Assess | ||||||
HER2 Kinase Domain Complexed with TAK-285 | monomer | 1×03P; | ||||
Assess | ||||||
HER2 in complex with JBJ-08-178-01 | monomer | 1×VOY; | ||||
Assess | ||||||
Crystal Structure of the Kinase domain of Human HER2 (erbB2). | monomer | 1×03Q; | ||||
Assess | ||||||
HER2 IN COMPLEX WITH A COVALENT INHIBITOR | monomer | 1×70I; | ||||
Assess |
3 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7mn5.1.C | monomer | 0.79 | 99.90 | |||
Assess | ||||||
3bbt.1.A | monomer | 0.69 | 1×FMM; | 72.90 | ||
Assess | ||||||
7syd.1.C | monomer | 0.68 | 53.11 | |||
Assess |